Clinical Trials on Moderate to Severe Plaque Psoriasis in New Zealand
Total 230 results
-
Idera Pharmaceuticals, Inc.CompletedModerate to Severe Plaque Psoriasis | Actively Extending Plaque PsoriasisUnited States
-
AbbVieCompleted
-
UCB Biopharma SRLCompletedModerate to Severe Chronic Plaque Psoriasis | Chronic Plaque PsoriasisUnited States, Australia, Belgium, Canada, France, Germany, Netherlands, Poland, Spain, Turkey, United Kingdom
-
UCB Biopharma SRLCompletedModerate to Severe Chronic Plaque Psoriasis | Chronic Plaque PsoriasisUnited States, Canada
-
Novartis PharmaceuticalsCompletedModerate to Severe Plaque PsoriasisUnited States
-
Sun Pharmaceutical Industries LimitedRecruitingModerate to Severe Plaque PsoriasisUnited States, El Salvador
-
UCB Biopharma SRLCompletedModerate to Severe Plaque Psoriasis | Chronic Plaque PsoriasisUnited States, Australia, Canada, Germany, Hungary, Korea, Republic of, Poland, Russian Federation, Taiwan
-
AbbVie (prior sponsor, Abbott)CompletedModerate to Severe Plaque PsoriasisUnited States, Austria, Belgium, Canada, Denmark, Finland, France, Germany, Greece, Italy, Spain, Sweden, Switzerland, United Kingdom
-
UCB Biopharma SRLCompletedModerate to Severe Chronic Plaque Psoriasis | Chronic Plaque PsoriasisUnited States, Australia, Belgium, Canada, Germany, Hungary, Italy, Japan, Korea, Republic of, Poland, Russian Federation, Taiwan, United Kingdom
-
Bausch Health Americas, Inc.TerminatedModerate to Severe Plaque PsoriasisUnited States, Austria, France, Poland, Australia, Czechia, Canada, Hungary, Portugal, Spain, Netherlands
-
TakedaNimbus Lakshmi, Inc.; Innovaderm Research Inc.CompletedModerate to Severe Plaque PsoriasisUnited States, Canada
-
UCB Biopharma SRLCompletedPsoriatic Arthritis | Moderate to Severe Chronic Plaque Psoriasis | Chronic Plaque PsoriasisUnited States, Australia, Canada, Germany, Hungary, Korea, Republic of, Poland, Russian Federation, United Kingdom
-
Genzyme, a Sanofi CompanyCompletedModerate to Severe Chronic Plaque PsoriasisUnited States
-
AbbVie (prior sponsor, Abbott)Paragon BiomedicalCompletedModerate to Severe Plaque PsoriasisUnited States
-
AbGenomics B.V Taiwan BranchCompletedModerate to Severe Chronic Plaque PsoriasisUnited States
-
AbGenomics B.V Taiwan BranchCompletedModerate to Severe Chronic Plaque PsoriasisUnited States
-
UCB Biopharma SRLCompletedPsoriatic Arthritis | Moderate to Severe Chronic Plaque Psoriasis | Chronic Plaque PsoriasisUnited States, Australia, Belgium, Canada, Germany, Hungary, Italy, Japan, Poland, Russian Federation, United Kingdom
-
Sun Pharmaceutical Industries LimitedActive, not recruitingChronic Plaque Psoriasis | Moderate to Severe Nail PsoriasisUnited States, Australia
-
Astellas Pharma IncBiogenCompleted
-
Janssen Biotech, Inc.CompletedModerate to Severe Plaque PsoriasisUnited States
-
Jiangsu HengRui Medicine Co., Ltd.CompletedModerate-to-severe Chronic Plaque PsoriasisUnited States, Australia, China
-
Novartis PharmaceuticalsCompletedModerate to Severe Plaque-type PsoriasisGermany, United States, Belgium, Colombia, Spain, Estonia, Hungary, Japan, Lithuania, Taiwan, Australia, Korea, Republic of, Canada, Singapore, Italy, Israel, Sweden, Guatemala, United Kingdom, Argentina, France, Poland, Latvia, Iceland, Finla... and more
-
Novartis PharmaceuticalsCompletedModerate to Severe Plaque-type PsoriasisUnited States, Czech Republic, Austria, Germany, India, Japan, Bulgaria, Singapore, Switzerland, United Kingdom, Italy, France, Poland, Slovakia, Canada, Vietnam
-
Novartis PharmaceuticalsCompletedModerate to Severe Chronic Plaque-Type PsoriasisUnited States, Germany, Japan, Bulgaria, Czechia, Singapore, Switzerland, United Kingdom, Italy, France, Vietnam, Poland, Slovakia, Austria, Canada
-
Novartis PharmaceuticalsCompletedModerate to Severe Plaque-type PsoriasisUnited States, Colombia, Estonia, Japan, Taiwan, Israel, Canada, Lithuania, Argentina, Latvia, Iceland, Mexico
-
Novartis PharmaceuticalsCompletedModerate to Severe Chronic Plaque-type PsoriasisUnited States, Hungary, Italy, Russian Federation, Germany, Czechia, Canada
-
Novartis PharmaceuticalsCompletedModerate to Severe Chronic Plaque-type PsoriasisBelgium, Spain, Russian Federation, Germany, United States, Czechia, Peru, Poland, Estonia
-
UCB Biopharma SRLRecruitingModerate Chronic Plaque Psoriasis | Severe Chronic Plaque Psoriasis | Mixed Guttate/Plaque PsoriasisUnited States, Canada, Puerto Rico
-
Bristol-Myers SquibbTerminatedPsoriasis, Moderate to SevereUnited States
-
Novartis PharmaceuticalsCompletedModerate to Severe Nail PsoriasisGermany, Belgium, Spain, United States, Australia, United Kingdom, Denmark, Czechia, Greece
-
AbbVieRecruitingPsoriasis | Moderate Plaque Psoriasis | Moderate PsoriasisGreece
-
Novartis PharmaceuticalsCompletedModerate to Severe Palmoplantar PsoriasisBelgium, United States, Hungary, Russian Federation, Turkey, Australia, Israel, Netherlands, Portugal, Spain, United Kingdom, Norway, Slovakia, Canada, Finland
-
Merz Pharmaceuticals GmbHCompletedModerate to Severe Glabellar Frown LinesUnited States
-
Croma-Pharma GmbHActive, not recruitingModerate to Severe Midface Volume DeficitUnited States
-
Janssen Research & Development, LLCRecruitingModerate Plaque PsoriasisUnited States, Canada
-
Kythera BiopharmaceuticalsCompletedEfficacy | Safety | Moderate to Severe Convexity of Submental FatUnited States
-
PfizerCompleted
-
Egalet LtdCompletedModerate-to-severe Chronic Noncancer PainUnited States
-
UCB Biopharma S.P.R.L.CompletedModerate and Severe Active Rheumatoid Arthritis | Active Psoriatic Arthritis | Active Ankylosing Spondylitis | Moderately to Severely Active Crohn's DiseaseUnited States
-
AbbottCompletedModerate to Severe Chronic, Non-malignant PainUnited States
-
University of PennsylvaniaPatient-Centered Outcomes Research Institute; University of Utah; National Psoriasis...Completed
-
KoBioLabsActive, not recruitingA Study to Investigate Efficacy and Safety of KBL697 in Patients With Moderate Plaque Type PsoriasisPsoriatic PlaqueUnited States, Australia
-
Regeneron PharmaceuticalsSanofiCompletedModerate to Severe Atopic Hand and Foot DermatitisUnited States, Germany, Japan, Poland
-
Kythera BiopharmaceuticalsCompletedModerate or Severe Submental FullnessUnited States
-
Icahn School of Medicine at Mount SinaiBausch Health Americas, Inc.CompletedPlaque Psoriasis | Palmoplantar PsoriasisUnited States
-
Icahn School of Medicine at Mount SinaiUCB Pharma; Psoriasis Treatment Center of Central New JerseyRecruiting
-
Egalet LtdCompletedModerate-to-severe Chronic Low Back PainUnited States
-
Astellas Pharma IncAstellas Pharma Canada, Inc.Terminated
-
Icahn School of Medicine at Mount SinaiCompleted